Elafibranor
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for Elafibranor, covering 2019-09-24 to 2026-07-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. [Phase 3]